# Myocardial Protection With Adenosine Preconditioning

> **NCT00881686** · PHASE1,PHASE2 · COMPLETED · sponsor: **Xijing Hospital** · enrollment: 238 (actual)

## Conditions studied

- Heart Defects, Congenital
- Cardiac Surgical Procedures
- Myocardial Reperfusion Injury
- Adenosine

## Interventions

- **DRUG:** adenosine

## Key facts

- **NCT ID:** NCT00881686
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 238 (ACTUAL)
- **Last updated:** 2009-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00881686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00881686, "Myocardial Protection With Adenosine Preconditioning". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00881686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*